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Nuclear domains (ND) 10 are associated with proteins implicated in transcriptional regulation, growth suppression, and
apoptosis. We now show that the minor capsid protein L2 of human papillomavirus (HPV) type 33 induces a reorganization
of ND10-associated proteins. Whereas the promyelocytic leukemia protein, the major structural component of ND10, was
unaffected by L2, Sp100 was released from ND10 upon L2 expression. The total cellular amount of Sp100, but not of Sp100
mRNA, decreased significantly, suggesting degradation of Sp100. Proteasome inhibitors induced the dispersal of Sp100 and
inhibited the nuclear translocation of L2. In contrast to Sp100, Daxx was recruited to ND10 by L2 expression. Coimmuno-
precipitation demonstrated interaction of the two proteins. L2-induced reorganization of ND10 was observed both in cell
culture and in natural HPV lesions. The differential change in protein composition observed provides further evidence toINTRODUCTION
The structural and functional organization of the cell
nucleus of higher eukaryotes is still not well understood.
In addition to accommodating the genomic chromatin,
the nucleus contains a number of nonchromatin struc-
tures, including nucleoli and nuclear bodies (Lamond
and Earnshaw, 1998). One class of nuclear bodies be-
came initially known as a target of autoantibodies in
patients with primary biliary cirrhosis (Sternsdorf et al.,
1997; Szostecki et al., 1990). This permitted the identifi-
cation of Sp100, a major constituent of these subnuclear
structures. Sp100 and its variants interact with members
of nonhistone chromatinal proteins and have been
shown to influence transcription and chromatin dynam-
ics (Seeler et al., 1998, 2001). Another major component
was later found to be the promyelocytic leukemia (PML)
protein, which was originally discovered as the fusion
partner of the retinoic acid receptor -oncogenic fusion
protein in patients with acute promyelocytic leukemia (de
The et al., 1990; Dyck et al., 1994; Goddard et al., 1991;
Kakizuka et al., 1991; Weis et al., 1994). Subsequently
these nuclear bodies were termed PML oncogenic do-
mains or nuclear dots (ND) 10 (Ascoli and Maul, 1991).
PML is the major structural component of ND10 (Ishov et
al., 1999; Zhong et al., 2000a) and seems to be strongly
1 To whom correspondence and reprint requests should be ad-
dressed at Institute for Medical Microbiology and Hygiene, Johannes-
Gutenberg-Universita¨t Mainz, Hochhaus am Augustusplatz, D-5510197associated with the nuclear matrix (Sternsdorf et al.,
1997). Several other proteins in addition to Sp100 and
PML have been found to be associated with ND10 (Maul
et al., 2000; Seeler and Dejean, 1999; Negorev and Maul,
2001). These include the ubiquitin-related protein
SUMO-1, which can modify PML and Sp100 through
covalent modification, the Fas-modulating protein Daxx,
which has also been shown to affect gene expression,
transcription factors (Sp1, CBP), tumor suppressors (p53,
pRb), proteasome components, proto-oncogenes, and
still others (Quignon et al., 1998; Sternsdorf et al., 1997;
Wang et al., 1998; Zhong et al., 2000a).
The function of ND10 has remained largely enigmatic.
Given the multitude of proteins that may associate with
these structures, albeit some only transiently, ND10 are
unlikely to serve any single specific function. They have
been proposed to be deposits of nuclear factors and
have been implicated in various cellular functions includ-
ing transcriptional regulation (Doucas, 2000; Li and
Chen, 2000; Li et al., 2000a), growth suppression (Gotti-
fredi and Prives, 2001), and apoptosis (Quignon et al.,
1998; Torii et al., 1999; Wang et al., 1998; Zhong et al.,
2000b). ND10 are dynamic structures that can vary in
number and size depending on cell type. They appear to
be associated with the nuclear matrix and are cell cycle-
regulated. The ND10 organization may change in neo-
plastic and inflammatory diseases or other cellular
stresses, and ND10-associated proteins are upregulated
by interferons (Guldner et al., 1992; Maul et al., 2000;
Sternsdorf et al., 1997; Everett, 2001). The more recentsuggest that the ND10-associated proteins are an important
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Specific proteins of a number of DNA viruses, includ-
ing herpes simplex virus (HSV), cytomegalovirus (CMV),
Epstein–Barr virus (EBV), and adenovirus, are targeted to
ND10 (Adamson and Kenney, 2001; Ishov and Maul, 1996;
Sternsdorf et al., 1997). The HSV ICPO, the CMV IE1, and
the EBV BZLF1 proteins specifically abrogate the
SUMO-1 modification of PML and/or Sp100, thereby in-
ducing a complete disruption of the ND10 structure (Ahn
et al., 1998; Everett et al., 1998; Everett and Maul, 1994;
Korioth et al., 1996; Muller and Dejean, 1999; Parkinson
and Everett, 2000). The E4orf3 protein of adenovirus
associates with PML and causes a dramatic reorganiza-
tion of ND10 (Carvalho et al., 1995). T-antigen of simian
virus 40 and nuclear antigen-5 of EBV have also been
found in association with ND10, as well as the E1 and E2
proteins of human papillomavirus (HPV) (Swindle et al.,
1999; Szekely et al., 1996; Tang et al., 2000). All of these
proteins are early proteins, which suggests that ND10
may play a role in the initiation of DNA replication of
these viruses. Recently the minor capsid protein (L2) of
bovine papillomavirus type 1 (BPV1) was found to accu-
mulate in ND10 and to recruit the major capsid protein
(L1) into these structures (Day et al., 1998). This suggests
that ND10 may also be a site of encapsidation of the viral
genome.
Papillomaviruses are a large group of DNA viruses of
higher eukaryotes that specifically infect epithelial cells
and replicate in terminally differentiating keratinocytes.
The 8-kb genome associates with histones to form a
minichromosome that is packaged into the viral capsid
(for review see Howley (1996)). The capsid is organized
into 72 capsomeres, pentamers of the major capsid pro-
tein L1, and contains several copies, possibly 12, of the
minor capsid protein L2 (Baker et al., 1991; Trus et al.,
1997). The function of L2 is not known exactly, but it has
been shown to be required both for infection and for
packaging of the viral DNA (Roden et al., 1996; Unckell et
al., 1997).
In this study we have analyzed the interaction of ND10
with the minor capsid protein of HPV33, a human papil-
lomavirus associated with malignant carcinoma (Beau-
denon et al., 1986). We show that this interaction induces
FIG. 1. L2 does not alter nuclear localization of PML. HuTK cells were grown on coverslips and subsequently coinfected for the indicated times
with VTF7-3 and vac33L2. Cells were stained for L2 and PML and visualized by DTAF- and Cy3-coupled secondary antibodies, respectively. The
indicated sections have been enlarged to more clearly demonstrate colocalization.
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major changes of ND10 affecting proteins that are tightly
associated with the nuclear matrix and that are involved
in transcriptional regulation. This provides for the first
time insight into the close link between this late viral
protein, nuclear subdomains, and regulators of transcrip-
tional repression and chromatin structure.
FIG. 2. L2-induced release of Sp100 from ND10. HuTK cells were grown on coverslips and subsequently coinfected with VTF7-3 and vac33L2 or
with VTF7-3 and vac33L1 for the indicated periods of time. Cells were stained for L2 and Sp100 or for L1 and Sp100 and visualized by DTAF- and
Cy3-coupled secondary antibodies, respectively.
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RESULTS
Association of ND10 with L2 does not affect PML
To study the association of ND10 with the papilloma-
virus minor capsid protein, L2, we visualized L2 and
ND10-associated proteins in human cell line HuTK by
indirect immunofluorescence. Similar results were ob-
tained with HeLa and KH cells. L2 was expressed using
vaccinia virus vac33L2 and helper virus VTF7-3 encoding
HPV33 L2 and T7 RNA polymerase, respectively. L2 ex-
pression was first detected 4 h after infection by diffuse
nuclear staining (not shown). Ten hours after infection it
localized mainly to ND10, which were identified by im-
munostaining of PML (Fig. 1). Another 10 h later the
L2-positive speckles had significantly expanded, sug-
gesting further accumulation. No change in the number
and intensity of PML foci could be detected in the course
of L2 expression (Fig. 1). This indicates that the core of
ND10, supposed to be formed by PML oligomers (Ishov
et al., 1999; Zhong et al., 2000a), is unaffected by L2. L2
colocalized with PML and continued to be deposited
around the PML cores as shown in the higher magnifi-
cation (Fig. 1).
Sp100 is released from ND10 by L2 expression
Another major constituent of ND10 besides PML is the
Sp100 protein. It has been reported to be firmly bound to
the nuclear matrix but not to PML and to exist in various
isoforms (Koken et al., 1994; Sternsdorf et al., 1997;
Seeler et al., 2001). Prior to infection of HuTK cells with
vaccinia virus, Sp100 was detected in ND10 (Fig. 2)
where it colocalized with PML, in agreement with previ-
ous results (not shown). Six hours after infection, when
L2 protein started to accumulate at ND10, colocalization
of L2 with Sp100 was observed (Fig. 2). However, 12 h
after infection Sp100 was no longer detectable by immu-
nostaining, indicating that it was released from ND10.
This effect was specific for L2 since neither VTF7-3 alone
nor coinfection of VTF7-3 and vac33L1 encoding the
HPV33 L1 capsid protein affected the association of
Sp100 with ND10 (Fig. 2).
To address the question of whether Sp100 was com-
mitted to degradation or merely dispersed in the nucle-
oplasm, we performed Western blots using whole-cell
extracts of cells infected with helper virus or helper virus
and vac33L2, respectively (Fig. 3A). The extracts con-
tained the same amount of PML, confirming that PML
was unaffected by L2 expression, as previously sug-
gested by immunostaining (Fig. 1). In contrast, the
amount of Sp100 was drastically reduced in cells ex-
pressing L2 (Fig. 3A), excluding nuclear dispersal.
We next sought to analyze whether Sp100 was down-
regulated by L2 at the level of transcription. To address
this issue, we performed Northern blots using RNA from
HuTK cells. Cells were either infected with vac33L2 and
helper virus or infected with helper virus alone, and RNA
was prepared 5, 10, and 24 h after infection. As shown in
Fig. 3B, Sp100 mRNA was detected as a single major
band of approximately 2.0 kb in all RNA preparations. At
24 h after infection a smaller RNA species was detected
as well. Although vaccinia-infected cells contained
somewhat less Sp100 mRNA than uninfected cells, the
level of Sp100 mRNA was independent of the expression
of L2. Clearly, the L2-induced reduction of the intracellu-
lar concentration of Sp100 was not caused by repression
of Sp100 transcription.
Recent studies indicate that ND10 are sites of proteo-
lytic degradation and associate with components of
the proteasome (Everett et al., 1997). This suggested to
us that the L2-induced diminution of Sp100 might be
due to proteolysis. Addressing this question, we ob-
served that proteasome inhibitors alone induced the
dispersion of Sp100 from ND10 in the absence of L2. In
addition, nuclear transport of L2 was blocked in the
presence of MG132 and other proteasome inhibitors,
thus preventing the use of these inhibitors to further
analyze the L2-induced loss of Sp100 from ND10 (data
not shown).
FIG. 3. Loss of Sp100 is not due to transcriptional repression. (A)
HuTK cells were infected for 24 h with VTF7-3 alone (VTF) or together
with vac33L2 (L2) and subsequently processed for Western blot anal-
ysis. The blots were stained using PML-specific (PML) and Sp100-
specific (Sp100) polyclonal antisera, respectively. Bound antibodies
were visualized by enhanced chemiluminescence (Amersham Pharma-
cia). (B) Total cell RNA was prepared from uninfected HuTK cells or
from cells infected with VTF7-3 alone (VTF) or together with vac33L2
(L2) for the indicated periods of time. RNA was subsequently subjected
to Northern blot analysis using a Sp100-specific probe. Radioactivity
was detected with a Molecular Dynamics phosphorimager (Storm 840).
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The transcriptional repressor Daxx is recruited into
ND10 by L2
Recent studies suggest that ND10 may be involved in
regulating transcriptional repression (Li et al., 2000a).
Since Daxx, a Fas-modulating protein that is located
mainly in the nucleus, can repress transcription and bind
to PML (Ishov et al., 1999), we were interested to know
how the accumulation of L2 affected the association of
Daxx with ND10. We initially addressed this question
using immunofluorescence staining of HuTK and KH
cells (Fig. 4). In the absence of L2, endogenous Daxx
localized to the nucleus in diffuse and weak punctate
patterns, which is in agreement with published reports
and represents heterochromatin and ND10 association,
respectively (Li et al., 2000a). Eight hours after infection
with vac33L2, Daxx was concentrating at ND10, where it
colocalized with L2 (Fig. 4). Twenty hours after infection
Daxx was heavily concentrated in gross L2-containing
nuclear bodies (Fig. 4), suggesting L2-induced attraction
of Daxx into these domains. This effect was L2-induced
since neither VTF7-3 alone nor VTF7-3 and vac33L1
encoding the HPV33 L1 capsid protein affected the as-
sociation of Daxx with ND10 (Fig. 4). Since the L2-medi-
ated accumulation of Daxx in ND10 suggested that L2
can associate with Daxx, we used immunoprecipitation
to verify this notion (Fig. 5). Whole-cell extracts were
prepared from uninfected cells, cells infected with the
VTF7-3 helper virus, and cells infected with vac33L2 and
helper virus. When submitted to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and
Western blotting, Daxx was detected as a 120-kDa pro-
tein in all extracts, as expected (Fig. 5). Since the amount
of Daxx in the extracts was about the same, the seem-
ingly lower level of Daxx in cells not synthesizing L2, as
suggested by immunostaining (Fig. 4), was probably due
to dispersal of Daxx throughout the nucleus. Immunopre-
cipitation of aliquots from these extracts was then car-
ried out using an L2-specific monoclonal antibody. We
used a Daxx-specific monoclonal antibody to probe for
the presence of Daxx in the immunoprecipitates in West-
ern blots. As shown in Fig. 5, Daxx was exclusively
detected in the extract of vac33L2-infected cells, al-
though it was present in all three extracts at similar
concentrations. We then stripped the Daxx antibody off
the membrane and reprobed the membrane with an
L2-specific antibody. L2 was detected only in vac33L2-
infected cells, as expected. This demonstrates that Daxx
interacts with L2, either directly or via an intermediate.
Reorganization of ND10 in natural lesions
Since the nuclear architecture of terminally differenti-
ating keratinocytes, in which papillomaviruses replicate,
may not exhibit the same distinctive substructures as the
cultured cells used in this work, we sought to analyze
whether L2 induces the reorganization of ND10 in natural
lesions. Paraffin-embedded sections of cervical intraepi-
thelial lesions (CIN II) infected with HPV33 were stained
for L2 and Sp100 (Figs. 6B and 6C). In addition, tissue
classified as normal (CIN0) was stained for Sp100 (Fig.
6A). Overviews of the sections after staining with hema-
toxilin are also shown. Probably due to paraffin inhibi-
tion, Daxx was not detectable with the available antibody.
The sections contained both enucleated keratinocytes
and live cells. Sp100 was detected in nuclear dots re-
sembling ND10 structures in normal tissue (CIN0) with
the exception of stratified cells of the upper layers (Fig.
6A). L2 was visualized in the nuclei of HPV-infected cells
in the upper layers but no Sp100 could be detected in
these cells (Fig. 6B). Sp100 was found only in a punctate
pattern in the lower layers of cells (Fig. 6B). In the
intermediate layers of cells displaying weak L2-specific
fluorescence, L2 colocalized with Sp100 in a punctate
pattern (Fig. 6C). We assume that these cells are at the
onset of L2 synthesis. This is in agreement with our
observation that at the beginning of L2 expression L2
and Sp100 colocalize in ND10 of cultured cells. These
results again suggest that the life cycle of this papillo-
mavirus involves reorganization of ND10 caused by the
minor capsid protein L2.
DISCUSSION
We have shown in this paper that the protein compo-
sition of ND10 in human cells is profoundly altered by the
minor capsid protein L2 of a papillomavirus: Sp100, a
major constituent of ND10, was released and probably
degraded, and Daxx, usually only partially colocalizing
with ND10, was heavily concentrated at ND10, whereas
PML was remarkably unaffected. We have confirmed that
these structural changes were specifically induced by L2
and not caused by the vaccinia virus used as vector.
Moreover, these observations were extended from cell
lines to human tissue: Sp100 was absent from keratino-
cytes expressing L2 in HPV-infected mucosa. This is
therefore the first case of a late viral protein inducing
differential changes in the protein composition of ND10
FIG. 5. L2 and Daxx coimmunoprecipitate. Nuclear extracts of unin-
fected HuTK cells () or cells infected for 24 h with VTF7-3 alone (VTF)
or together with vac33L2 (L2) were subjected to Western blot analysis
using a Daxx-specific polyclonal antiserum (left). Aliquots of the same
extracts were subjected to immunoprecipitation (IP) using monoclonal
antibody 33L2-1 (L2, Daxx). The immunoprecipitates were analyzed by
Western blot using a Daxx-specific antibody (Daxx). The antibody was
subsequently stripped off the membrane, and the membrane was
reprobed using 33L2-1 (L2).
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and clearly different from the observations made for
large DNA viruses that completely disrupt the ND10
(Everett et al., 1998; Muller and Dejean, 1999; Parkinson
and Everett, 2000).
Although infections by vaccinia virus are lytic, most
cells remained intact for at least 24 h. This allowed us to
study the L2-induced changes of ND10 for up to 20 h. The
time course of disappearance of Sp100 and acquisition
of Daxx suggested that the two processes were physi-
cally uncoordinated: Daxx continued to accumulate at
ND10 even after loss of Sp100. In contrast, the aquisition
of Daxx was highest in cells showing the largest depo-
sition of L2 (Fig. 5), suggesting interaction between the
two proteins. This notion was confirmed by coimmuno-
precipitation, suggesting association of Daxx with L2,
either directly or via an intermediate. It is not clear at the
FIG. 4. L2-induced accumulation of Daxx in ND10. HuTK cells were grown on coverslips and subsequently coinfected with VTF7-3 and vac33L2
or with VTF7-3 and vac33L1 for the indicated periods of time. Cells were stained for L2 and Daxx or for L1 and Daxx and visualized by DTAF- and
Cy3-coupled secondary antibodies, respectively.
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moment whether accumulation of Daxx is due to an
increased rate of association with ND10 or whether it is
triggered by a decreased off-rate. Our observation that
Sp100 was removed from cells expressing L2, whereas
the steady-state level of Sp100 mRNA was unchanged,
suggested proteolysis of Sp100. Specific inhibition of
translation could be an alternative explanation. At the
present time we cannot distinguish between these pos-
sibilities. Proteasome inhibitors like MG132 not only pre-
vented L2 from entering into the nucleus but also caused
FIG. 6. Loss of Sp100 in HPV-infected lesions. Paraffin-embedded tissue sections obtained from a biopsy of normal tissue classified as CIN0 (A)
and from a biopsy containing HPV-33 (B, C) were deparaffinized and were subsequently stained for Sp100 (A) or L2 and Sp100 (B, C). Overviews of
the hematoxilin-stained adjacent sections are also shown. The indicated areas were enlarged for immunohistochemical analysis. (A) Sp100-positive
nuclear dots in the upper layers of normal tissue are highlighted by arrows. (B) Analysis of L2 and Sp100 in the upper layers of HPV-33-infected genital
mucosa. (C) Enlargement of the transition zone of B displaying the onset of L2 expression. Arrows depict regions of colocalization. Bars represent
50 m.
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a redistribution of ND10-associated proteins (data not
shown). Very recent data also suggest that ND10-asso-
ciated proteins move to the nucleolus upon treatment
with MG132 (Mattsson et al., 2001).
The characterization of the virus-induced changes has
implications for understanding the ND10 functions. Sev-
eral viruses have been shown to disintegrate ND10
through the action of immediate-early proteins (Parkin-
son and Everett, 2000). Since their replication is reduced
when the disintegration is inhibited, it has been postu-
lated that ND10 store essential factors, which are re-
leased by the disintegration of the ND10 (Burkham et al.,
2001). However, this does not hold true for papillomavi-
rus. The papillomavirus replication proteins E1 and E2
have previously been shown to colocalize with PML at
ND10, and the synthesis of viral DNA was also localized
at or near ND10 (Swindle et al., 1999). Clearly no disin-
tegration is required for replication of papillomavirus
DNA. Similar results have been obtained for simian vi-
rus 40, which also requires ND10 localization for DNA
synthesis (Tang et al., 2000). The multiplication of papil-
lomaviruses is coordinated with the differentiation of
the keratinocytes of epithelia and mucosa. The capsid
proteins L1 and L2 are synthesized only at the final
stage of terminal differentiation, when the viral DNA is
encapsidated as minichromosomes to form complete
virions (Howley, 1996). The L2-induced structural
changes of the ND10 indicate that these nuclear bodies
have additional functions that need to be modified in
order to allow the final assembly of papillomavirus par-
ticles.
The acquisition of Daxx to ND10 and the release of
Sp100 in the final stage of papillomavirus assembly in-
vites the following speculation. Daxx is a nuclear protein
with multiple functions (Charette et al., 2000; Michaelson,
2000). It inactivates transcriptional activators like Pax
and ETS1 through direct interaction (Hollenbach et al.,
1999; Lehembre et al., 2001; Li et al., 2000b) and binds
and relocates histone deacetylase (Li et al., 2000a) caus-
ing a condensation of chromatin. Daxx may therefore
play a role in the repression of viral replication and
transcription. The Sp100 protein, on the other hand, has
recently been shown to bind nonhistone proteins and
affect chromatin dynamics (Seeler et al., 1998). Since the
major capsid protein, L1, is recruited to ND10 only after
release of Sp100 (L.F., R.E.S., and M.S., unpublished
observations) the loss of Sp100 might facilitate the pack-
aging of the viral minichromosome.
The L2 protein may become a useful tool for the
analysis of ND10 structure and function. The L2-induced
reorganization of ND10 should help to elucidate its cel-
lular function, as other viral proteins have in the past
been extremely useful in unraveling the mechanisms of
cell cycle control and tumorigenesis.
MATERIALS AND METHODS
Cell lines, recombinant vaccinia viruses, and
antibodies
HuTK 143B is an osteosarcoma cell line defective for
thymidine kinase (Moss et al., 1990). The generation of
recombinant vaccinia viruses vac33L1 and vac33L2 has
been described (Unckell et al., 1997). VTF7-3 was kindly
provided by B. Moss (Moss et al., 1990). L1- and L2-
specific mouse monoclonal (Sapp et al., 1994; Volpers et
al., 1995) and rabbit polyclonal antibodies (Volpers et al.,
1993) have been described. The Sp100 antibody was
kindly provided by H. Will. PML- and Daxx-specific anti-
bodies were obtained from Chemicon and Santa Cruz,
respectively. Proteasome inhibitors MG132 (Sigma Al-
drich; 5 M), Lactacystin (BIOMOL; 10 M), and
N-acetyl-leu-leu-norleucinal (ALLN) (BIOMOL; 25 M)
were diluted according to the manufacturers’ sugges-
tions.
Infection of cells
Confluent HuTK cells were split 1:4 and grown for
24 h at 37°C in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum and
antibiotics (Life Technologies). Cells were washed once
with phosphate-buffered saline (PBS) and subsequently
infected with recombinant vaccinia viruses diluted in
serum-free DMEM at a multiplicity of infection of 2 for
each virus. After incubation for 1 h at room temperature,
cells were washed once with PBS and covered with
supplemented DMEM. Cells were processed for Western
blotting, immunoprecipitation, and immunofluorescence
after the indicated periods of time at 37°C, respectively.
Immunofluorescence
Cells grown on coverslips and infected with vaccinia
viruses as described above were fixated with methanol–
0.02 M EGTA (20°C) for at least 10 min, washed twice
with PBS, and blocked in 5% goat serum dissolved in
PBS. Coverslips were then incubated for 1 h at 37°C with
the indicated antibodies. After being washed with PBS,
the coverslips were incubated for 1 h at 37°C with
Cy3-conjugated Affinipure goat anti-rabbit IgG and DTAF-
conjugated Affinipure goat anti-mouse IgG (Jackson Im-
munoResearch Products). Coverslips were subsequently
washed extensively with PBS and mounted onto slides
using Vectashield mounting medium (Camon). Pictures
were taken using a Leica DM RBE fluorescence micro-
scope and a KOHU digital camera at an instrumental
magnification of 630. Software for merging pictures was
obtained from Applied Imaging Corp., U.S.A.
Northern blot analysis
A total of 4  105 HuTK cells were seeded into
six-well plates and grown overnight in supplemented
104 FLORIN ET AL.
DMEM. They were subsequently infected with the indi-
cated recombinant vaccinia viruses for 1 h at room tem-
perature and incubated for the indicated periods of time.
For each time point uninfected HuTK cells served as
control. Total RNA was isolated from the cells using the
RNA extraction kit E.Z.N.A (peqlab, Erlangen, Germany).
The amount of RNA was quantitated by densitometry,
and similar amounts (10 g RNA/lane) were size-frac-
tionated in a 1.2% agarose–2.2 M formaldehyde gel and
transferred to Hybond-N membrane (Amersham) using
10 SSC (modified from Fourney et al. (1988)). The mem-
brane was baked for 2 h at 80°C, prehybridized for 4 h at
42°C in 6 SSC, 0.5% SDS, 5 Denhardt’s solution, 50%
formamide, 250 g/ml denatured fragmented salmon
sperm DNA, and hybridized with a Sp100-specific DNA.
The Sp100 probe was generated by RT-PCR using the
synthetic oligonucleotides 1223/1241 (5-AGAGTGATAG-
GACAAGACC-3) and 1518/1536 (5-CGTCTGGAAACAG-
CAGCT-3) according to Accession No. NM_003113 and
total RNA from 293 cells. The resulting 314-bp fragment
was purified from agarose gel using the JETSORB DNA
extraction kit (Genomed, Bad Oeynhausen, Germany),
submitted to sequence analysis, and labeled with
[32P]dATP (Feinberg and Vogelstein, 1983). After over-
night hybridization the blot was washed three times with
2 SSC, 0.2% SDS at 42°C and three times with 0.2
SSC, 0.2% SDS at 60°C and analyzed by phosphorImag-
ing (Molecular Dynamics, Krefeld, Germany). RNA trans-
fer was confirmed by methylene blue staining of the
membrane. The data were analyzed using Image Quant
1.2 software.
Immunoprecipitation
For immunoprecipitation, 106 cells, either uninfected or
infected for 20 h with VTF7-3, or VTF7-3 and vac33L2,
respectively, were harvested, washed once with PBS,
and suspended in 1 ml of 10 mM Tris–HCl–10 mM KCl–
1.5 mM MgCl2–0.5% Nonidet-P40 (pH 7.5) supplemented
with 10 g/ml each of leupeptin and aprotinin. Cells were
broken in a Dounce homogenizer (tight pestle), nuclei
were collected, and proteins were extracted by sonica-
tion for 30 s at 40% output and 50% interval using a
Branson Sonifier 250. The lysate was cleared by centrif-
ugation and added to goat anti-mouse IgG-coated Dyna-
beads (Dynal) to which monoclonal antibody 33L2-1 had
previously been coupled. After 2 h at 4°C at constant
agitation the beads were collected and washed four
times with 1 ml each of ice-cold PBS. Bound proteins
were eluted with 1% SDS at 100°C and subsequently
analyzed by SDS–PAGE followed by Western blot using
the Daxx-specific monoclonal antibody and horseradish
peroxidase-coupled secondary antibody. The signal was
visualized by enhanced chemiluminescence (Amersham
Pharmacia). The membrane was subsequently stripped
off the antibody in 0.2 M sodium hydroxide for 10 min at
room temperature, washed with H2O and PBS–0.2%
Tween for 5 min and 24 h, respectively, and reprobed
using mAb 33L2-1.
Immunostaining of tissue sections
Paraffin-embedded HPV33-positive CIN II lesions,
which were mounted on slides, were deparaffinized with
xylol and subsequently rehydrated for 10 min each in
decreasing concentrations of ethanol (90, 70, and 50%).
The slides were rinsed with water, placed in a cuvette
containing citric buffer, and subsequently boiled for 15
min in a microwave oven. After the slides were washed
for 15 min immunostaining was performed as described
above.
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